Search results
Showing 871 to 885 of 2028 results for nice guidelines
Biographies for all current members of the diagnostics advisory committee.
pelvic organ prolapse, see NICE's decision aid on treating complications from mesh used for pelvic organ prolapse...
urinary incontinence, see NICE's decision aid on treating complications from mesh used for stress urinary incontinence...
NICE has developed a medtech innovation briefing (MIB) on Optowire for measuring fractional flow reserve .
Tolvaptan for treating autosomal dominant polycystic kidney disease (TA358)
Evidence-based recommendations on tolvaptan (Jinarc) for treating autosomal dominant polycystic kidney disease in adults.
NICE has developed a medtech innovation briefing (MIB) on the Quantitative Timed Up and Go (QTUG)
NICE has developed a medtech innovation briefing (MIB) on PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection .
NICE has developed a medtech innovation briefing (MIB) on Thora 3Di for assessing asthma in children .
Processes and methods for NICE-wide guidance surveillance (PMG49)
This guide describes the methods and processes that NICE follows to assess the impact of new evidence, changes to the health and care system, or other new, relevant information that has come to light after NICE guidance has published
Evidence-based recommendations on dapagliflozin (Forxiga) for treating chronic heart failure with preserved or mildly reduced ejection fraction in adults.
Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel) and ustekinumab (Stelara) for plaque psoriasis in children and young people.
Evidence-based recommendations on Memokath 051 Ureter stent for ureteric obstruction.
Evidence-based recommendations on reslizumab (Cinqaero) for treating severe eosinophilic asthma in adults.